{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-009384","form_type":"8-K","ticker":"WGRX","cik":"0002030763","company_name":"Wellgistics Health, Inc.","filed_at":"2026-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.050190+00:00","generated_at":"2026-05-15T18:15:12.681841+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Wellgistics launches medical food Forzet for GLP-1 muscle loss targeting $70B market","bullets":["Forzet is a medical food for dietary management of muscle loss during weight loss therapies, aimed at GLP-1 drug users.","GLP-1 agonist market forecast to grow from $70B (2025) to $201B (2030) per Grandview Research.","Forzet has been evaluated in multiple controlled clinical studies (Type 2 diabetes, heart failure, COPD) in Europe.","Product is classified as medical food, not FDA-approved drug; available OTC under physician supervision.","Initial availability through Wellgistics affiliated pharmacy and select network pharmacies; no revenue guidance provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-009384","json":"https://secwatch.observer/filing/0001493152-26-009384.json","markdown":"https://secwatch.observer/filing/0001493152-26-009384.md","text":"https://secwatch.observer/filing/0001493152-26-009384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226009384/0001493152-26-009384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226009384/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T18:15:12.681841+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001520138-26-000200","ticker":"FNGR","company_name":"FingerMotion, Inc.","filed_at":"2026-06-02T20:15:25+00:00","headline":"FingerMotion evaluating AI-HPC and geographic expansion as part of strategic evolution","event_type":"other_material","sec_items":["7.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001520138-26-000200","json":"https://secwatch.observer/filing/0001520138-26-000200.json","markdown":"https://secwatch.observer/filing/0001520138-26-000200.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1602409/000152013826000200/0001520138-26-000200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1602409/000152013826000200/fngr-06022026_8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-252598","ticker":"ICMB","company_name":"Investcorp Credit Management BDC, Inc.","filed_at":"2026-06-02T12:30:06+00:00","headline":"Investcorp Credit Management BDC sells entire Work Genius position for ~$10.3M","event_type":"other_material","sec_items":["7.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252598","json":"https://secwatch.observer/filing/0001193125-26-252598.json","markdown":"https://secwatch.observer/filing/0001193125-26-252598.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1578348/000119312526252598/0001193125-26-252598-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1578348/000119312526252598/d124777d8k.htm"},"side_by_side_evidence":null},{"accession":"0001477932-26-003569","ticker":"KIDZ","company_name":"Classover Holdings, Inc.","filed_at":"2026-06-02T12:15:32+00:00","headline":"KIDZ AI pivots digital asset treasury from Solana to Hyperliquid and stablecoin yield strategies","event_type":"other_material","sec_items":["7.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-003569","json":"https://secwatch.observer/filing/0001477932-26-003569.json","markdown":"https://secwatch.observer/filing/0001477932-26-003569.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022308/000147793226003569/0001477932-26-003569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022308/000147793226003569/class_8k.htm"},"side_by_side_evidence":null},{"accession":"0001993004-26-000042","ticker":"NWE","company_name":"NorthWestern Energy Group, Inc.","filed_at":"2026-06-02T11:14:00+00:00","headline":"NorthWestern Energy reaffirms 2026 non-GAAP EPS guidance $3.68-$3.83 at investor meetings","event_type":"other_material","sec_items":["7.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001993004-26-000042","json":"https://secwatch.observer/filing/0001993004-26-000042.json","markdown":"https://secwatch.observer/filing/0001993004-26-000042.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1993004/000199300426000042/0001993004-26-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1993004/000199300426000042/nwe-20260602.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026696","ticker":"LTRN","company_name":"Lantern Pharma Inc.","filed_at":"2026-06-01T23:40:29+00:00","headline":"Lantern Pharma uses presentation to discuss Harmonic Phase 2 trial of LP-300","event_type":"other_material","sec_items":["7.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026696","json":"https://secwatch.observer/filing/0001493152-26-026696.json","markdown":"https://secwatch.observer/filing/0001493152-26-026696.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000149315226026696/0001493152-26-026696-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000149315226026696/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001437749-26-019196","ticker":"NRXP","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2026-06-02T21:30:08+00:00","headline":"NRx Pharmaceuticals proposes public offering of common stock; terms not set","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-019196","json":"https://secwatch.observer/filing/0001437749-26-019196.json","markdown":"https://secwatch.observer/filing/0001437749-26-019196.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/0001437749-26-019196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/nrxp20260602_8k.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-064277","ticker":"TOPP","company_name":"Toppoint Holdings Inc.","filed_at":"2026-06-02T21:10:16+00:00","headline":"Topppoint issues statement at NYSE request; no undisclosed material developments behind unusual trading","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-064277","json":"https://secwatch.observer/filing/0001213900-26-064277.json","markdown":"https://secwatch.observer/filing/0001213900-26-064277.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1960847/000121390026064277/0001213900-26-064277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1960847/000121390026064277/ea0293039-8k_toppoint.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-253795","ticker":"AVA","company_name":"AVISTA CORP","filed_at":"2026-06-02T21:02:55+00:00","headline":"Avista signs non-binding MOU for 125 MW load, expandable to 500 MW by 2032","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253795","json":"https://secwatch.observer/filing/0001193125-26-253795.json","markdown":"https://secwatch.observer/filing/0001193125-26-253795.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/0001193125-26-253795-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/ava-20260529.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}